-
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
13 May 2024 14:30 GMT
… , Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 … molecular anchors, which can attach Amgen directly on to Matrix, and …
-
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
14 May 2024 11:30 GMT
PYX-201 Phase 1 trial clinical readout on track for fall of 2024
Executive Leadership Team expanded with the appointment of Stephen Worsley as Senior Vice President, Chief Business Officer PYX-106 Phase 1 trial clinical readout on track for 2H 2024 …
-
Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript
10 May 2024 21:52 GMT
… (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript May 9, 2024 … measure. Please refer to our earnings release furnished with the SEC … pipeline, since our last earnings call along with our next … with bemarituzumab in collaboration with Amgen and are acquaint to …
-
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript
10 May 2024 20:01 GMT
… , Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript May 10, 2024 … document provided in today’s earnings press release. Flip ahead to … , as mentioned on our prior earnings call, we plan to expand … targets, if you look at Amgen’s steep by CD3 was …
-
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript
10 May 2024 17:16 GMT
… Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is … olpasiran, being conducted by Amgen. We originally licensed olpasiran, … previously called AROLPA, to Amgen in 2016 and then … additional $375 million from Amgen and $110 million from …
-
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
10 May 2024 17:16 GMT
… (NASDAQ:XERS) Q1 2024 Earnings Call Transcript May 9, 2024 … please refer to our earnings press release and risk factors … in January, we announced Amgen had executed the exclusive … we announced in January, Amgen executed the exclusive license agreement …
-
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
10 May 2024 08:28 GMT
… (MGNX 0.07%)
Q1 2024 Earnings Call
May 09, 2024, 4 … provided in today's earnings press release. Flip ahead to … , as mentioned on our prior earnings call, we plan to expand … targets, if you look at Amgen's STEAP1 by CD3 …
-
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
09 May 2024 20:50 GMT
…
CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 … closely with Bristol Myers Squibb, Amgen, Astellas, Regeneron, and … we’re working with partners Amgen, Astellas, Regeneron, and BMS … is somewhat similar to Amgen’s Tarlatamab that has …
-
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript
09 May 2024 16:48 GMT
… Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript May 8, 2024 … strategic objectives. On our last earnings call, we announced that we … anything on the part of Amgen regarding marketing strategy with RAVICTI … t really comment on what Amgen is doing, but we know …
-
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript
09 May 2024 14:48 GMT
… . (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript May 8, 2024 …
Viridian Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0 … to our first quarter 2024 earnings conference call. The press … . I mean, I know Amgen is trying to understand that …